FDA considers applying regulations to liquid nicotine and other tobacco products.
Although the topic is still up for debate, the Food and Drug Administration (FDA) has concerns about liquid nicotine exposure, especially to children and infants. The FDA has researched the effects of accidental nicotine exposure, but they are looking for more information.
According to a report by the National Association of Tobacco Outlets (NATO), the FDA has issued an Advance Notice of Proposed Rulemaking (ANPRM) to request public comments, information, data, and research studies regarding exposure warnings and childproof packaging for liquid nicotine products and potentially other tobacco products, such as novel products, dissolvables, lotions, drinks and other products.
The FDA has performed its own research on the risks of accidental nicotine exposure, and has decided to seek more information on whether the toxicity of nicotine warrants requiring child resistant packaging of some tobacco products, and/or warning the public about the dangers of nicotine exposure, especially to children and infants.
The ANPRM issued by the FDA includes a number of questions about text warnings and child resistant packaging for liquid nicotine products, as well as other tobacco products.
According to the report by NATO, some of the key questions in the ANPRM include:
Should FDA consider requiring nicotine exposure warning text on liquid nicotine?
AND
Should FDA require child-resistant packaging for liquid nicotine?
All submitted public comments on this issue will be considered in the FDA’s decision on whether to draft the proposed regulations. If the FDA decides to issue a set of regulations, the public will have another opportunity to comment on the proposed regulations after a Notice of Proposed Rulemaking is issued in the Federal Register. The comment period for the current ANPRM began July 1, 2015 and will run for 60 total days.
